🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention

RecruitingNAAges 18 Years - 65 YearsMaleColumbia University
NCT06785376 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP/PrEP navigation program. The evaluation will apply use a 2x2 factorial design to randomize and follow for 18 months 480 PrEP-eligible Black MSM (aged 18-65) living in the NYC area to one of four combinations of interventions. The impact of the social/media campaign, delivered to both geographic (print media) and Black MSM communities (social media) and launched midway through recruitment, will be assessed through assessment of timing and length of exposure as covariates in analysis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Assigned biological male sex at birth * 18-65 years of age * Self-identify as: Black, African-American, Afro-Caribbean, Black African, Afro-Latino or multiethnic Black * Reside in the NYC metro area * Not HIV-positive (tested before randomization) * Report insertive or receptive anal intercourse with another man in the past six months * Not currently on PEP or PrEP * Can communicate in English or Spanish * Provide informed consent for the study * Any sexual identity Exclusion Criteria: * Unable to conduct a rapid HIV-self test to confirm self-reported HIV-negative status
💊

What it tests

  • DIY (Do It Yourself)
  • TRUST
  • SOC
📍

Where

1 site
Columbia University
New York, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy